Come visit us at booth #2 and discover MaxCyte's cGMP-compliant non-viral cell engineering platform and how it enables the acceleration of therapeutic development from concept to clinic.
While at the meeting, attend our feature presentation:
Featured Event
Next-generation CAR-based immunotherapies
Date: February 28, 2024
Time: 12:00 - 12:30 PM
Presenter: Sabrina Prommersberger, Postdoc, T-CURX
Abstract
Significant efforts have been invested in the development of advanced genetic engineering methods for immune effector cells targeting cancer cells. In this talk, optimized virus-free gene editing strategies for CAR T cells, refinement of clinical translation and the impact on their application will be presented. Insights into future directions to accelerate and amplify production to deliver CAR products with curative potential will be explored.
